Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BioLineRx Ltd.

Regulatory Filings • Jan 22, 2018

6692_rns_2018-01-22_0a1897dd-a237-45fb-87c9-6a80b45b870a.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: January 19, 2018 4:30 P.M. Form: F-3 CIK: 0001498403

Company Name: BioLineRx Ltd.

File Number: 333-222332

More from BioLineRx Ltd.

Foreign Filer Report 2025
Nov 24
Foreign Filer Report 2025
Nov 24
Foreign Filer Report 2025
Nov 17
Regulatory Filings 2025
Nov 17
Foreign Filer Report 2025
Sep 29
Foreign Filer Report 2025
Sep 29
Foreign Filer Report 2025
Aug 14
Earnings Release 2025
Aug 14
Prospectus 2025
Jul 26
Prospectus 2025
Jul 26
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.